Tesamorelin

Growth hormone axisFDA-approved (HIV visceral fat)Banned in sport (WADA)

Also known as: Egrifta

A GHRH analog that raises the body's own growth hormone. Approved to reduce belly fat in people with HIV.

Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.

How it works

Stimulates the pituitary to release growth hormone in natural pulses, which raises IGF-1 and targets visceral fat.

Evidence by goal

GoalGradeWhat the grade means
Fat loss & weightAApproved for this use or large randomized trials
Blood sugar & metabolicBHuman trials (smaller, mixed, or approved outside the US)
Muscle & growth hormoneBHuman trials (smaller, mixed, or approved outside the US)
Focus, memory & brainBHuman trials (smaller, mixed, or approved outside the US)

At a glance

Route
Subcutaneous daily
Half-life
About 30 minutes

Reported dosing

Label: 1.4 mg (Egrifta SV) or 2 mg daily.

Timing: Once daily; many clinicians prefer bedtime on an empty stomach to match the natural nighttime GH pulse.

Cycle: Continuous in trials (26 to 52 weeks). Benefits fade after stopping.

From approved labels where they exist, otherwise from published trials and practitioner reports.

Side effects

  • Injection-site reactions
  • Joint pain, fluid retention, numbness
  • Raised blood sugar

Who should avoid it

  • Pregnancy
  • Active cancer
  • Pituitary disorders or prior pituitary surgery

Often combined with

Sometimes paired with a GHRP such as ipamorelin in practitioner protocols.

Key findings

Reduced visceral fat about 15 to 18% in trials and reduced liver fat. A 2012 trial in older adults found better executive function.

Where it is legal (Oct 2026)

USPrescription
CanadaPrescription
MexicoNot approved
EUNot approved

Sources

Open Tesamorelin in the Peptide Guide Compare all peptides by goal

Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.

Natoorales and e4life.io (Mexico residency and immigration help) are sister businesses founded by Ian Kain.

Scroll to Top